Synlico Inc.
Synlico Inc. is a pioneering biotechnology company focused on revolutionizing medicine through AI-driven drug discovery and causal cell modeling. Their mission is to develop potent therapies for various diseases by integrating artificial intelligence, single-cell bioinformatics, and causal modeling to make cellular processes explainable, predictable, and engineerable.
Industries
Nr. of Employees
small (1-50)
Synlico Inc.
329 Oyster Point Boulevard, 3rd Floor, South San Francisco, CA, US 94080
Products
Causal AI platform for predicting cell behavior
A computational platform that integrates causal discovery, machine learning, and single-cell bioinformatics to predict how genetic or cellular interventions alter cell behavior in patient microenvironments, and to inform targeted therapeutic design.
Causal AI platform for predicting cell behavior
A computational platform that integrates causal discovery, machine learning, and single-cell bioinformatics to predict how genetic or cellular interventions alter cell behavior in patient microenvironments, and to inform targeted therapeutic design.
Services
Partnerships and collaborative research using causal inference and single-cell analysis to support design and prediction of therapeutic interventions.
Participation in industry challenges and presentations to pharmaceutical R&D and data science leadership for external validation and partner discovery.
Design and implementation of scalable pipelines for processing single-cell and other genomic datasets to support downstream modeling and analysis.
Partnerships and collaborative research using causal inference and single-cell analysis to support design and prediction of therapeutic interventions.
Participation in industry challenges and presentations to pharmaceutical R&D and data science leadership for external validation and partner discovery.
Design and implementation of scalable pipelines for processing single-cell and other genomic datasets to support downstream modeling and analysis.
Expertise Areas
- AI-driven drug discovery
- Single-cell bioinformatics
- Causal inference in biology
- Machine learning for biological data
Key Technologies
- Causal discovery algorithms
- Deep learning / machine learning
- Single-cell RNA sequencing analysis
- Scalable bioinformatics pipelines
News & Updates
Synlico Inc. was selected as a finalist in Johnson & Johnson Innovation’s QuickFire Challenge, showcasing their CausalCell AI platform to accelerate pharmaceutical R&D.
Synlico was selected as a finalist in a competitive challenge to showcase their AI platform for pharmaceutical R&D.
Synlico Inc. was selected as a finalist in Johnson & Johnson Innovation’s QuickFire Challenge, showcasing their CausalCell AI platform to accelerate pharmaceutical R&D.
Synlico was selected as a finalist in a competitive challenge to showcase their AI platform for pharmaceutical R&D.